Immunological activation following transcutaneous delivery of HR-gp100 protein

Vaccine

Volumn 25, Issue 23, 2007, Pages 4564-4570

  Frankenburg, Shoshana ^a   Grinberg, Igor ^b   Bazak, Ziva ^a   Fingerut, Lena ^c   Pitcovski, Jacob ^c   Gorodetsky, Raphael ^a   Peretz, Tamar ^a   Spira, Ram M ^d   Skornik, Yehuda ^e   Goldstein, Ronald S ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Langerhans cells; Melanoma; Transcutaneous vaccination

Indexed keywords

ENTEROTOXIN; GLYCOPROTEIN GP 100; PROTEIN HR GP100; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; LANGERHANS CELL; MELANOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD1; HUMANS; IMMUNIZATION; IMMUNOGLOBULINS; LANGERHANS CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SKIN;

EID: 34248334248     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.025     Document Type: Article

References (30)

1. Hammond S.A., Walwender D., Alving C.R., and Glenn G.M. Transcutaneous immunization: T cell responses and boosting of existing immunity. Vaccine 19 (2001) 2701-2707
2. Cerundolo V., Hermans I.F., and Salio M. Dendritic cells: a journey from laboratory to clinic. Nat Immunol 5 (2004) 7-10
3. Kotloff K.L., Sztein M.B., Wasserman S.S., Losonsky G.A., DiLorenzo S.C., and Walker R.I. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69 (2001) 3581-3590
4. Neidleman J.A., Vajdy M., Ugozzoli M., Ott G., and O'Hagan D. Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55. Immunology 101 (2000) 154-160
5. Simmons C.P., Hussell T., Sparer T., Walzl G., Openshaw P., and Dougan G. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses. J Immunol 166 (2001) 1106-1113
6. Scharton-Kersten T., Glenn G.M., Vassell R., Yu J., Walwender D., and Alving C.R. Principles of transcutaneous immunization using cholera toxin as an adjuvant. Vaccine 17 Suppl. 2 (1999) S37-S43
7. Beignon A.S., Briand J.P., Rappuoli R., Muller S., and Partidos C.D. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin. Infect Immun 70 (2002) 3012-3019
8. Pitcovski J., Bazak Z., Wasserman E., Elias O., Levy A., Peretz P., et al. Heat labile enterotoxin of E. coli-a potential adjuvant for transcutaneous cancer immunotherapy. Vaccine 24 (2006) 636-643
9. Gelbart Y., Frankenburg S., Pinchasov Y., Krispel S., Eliahu D., Drize O., et al. Production and purification of melanoma gp100 antigen and polyclonal antibodies. Protein Express Purif 34 (2004) 183-189
10. Frankenburg S., Elias E., Gelbart Y., Drize O., Lotem M., Ingber A., et al. Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patients. Immunol Lett 94 (2004) 253-259
11. Gorodetsky R., Vexler A., Shamir M., An J., Levdansky L., Shimeliovich I., et al. New cell attachment peptide sequences from conserved epitopes in the carboxy termini of fibrinogen. Exp Cell Res 287 (2003) 116-129
12. Gorodetsky R., Levdansky L., Vexler A., Shimeliovich I., Kassis I., Ben-Moshe M., et al. Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-chain termini. J Control Rel 95 (2004) 477-488
13. Pistoor F.H.M., Rambukkana A., Kroezen M., Lepoittevin J.P., Bos J.D., Kapsenberg M.L., et al. Novel predictive assay for contact allergens using human skin explant cultures. Am J Pathol 149 (1996) 337-343
14. Flaxman B.A., and Harper R.A. Organ culture of human skin in chemically defined medium. J Invest Dermatol 64 (1975) 96-99
15. Varani J., Fligiel S.E.G., Perone P., Inman D.R., and Voorhees J.J. Effects of sodium lauryl sulfate on human skin in organ culture: comparison with all trans retinoic acid and epidermal growth factor. Dermatology (1993) 19-25
16. Goodpasture W., et al. A study of human skin grafted to the chorio-allantois of chick embryos. J Exp Med 68 (1938) 891-904
17. Kunzi-Rapp K., Ruck A., and Kaufmann R. Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch Dermatol Res 291 (1999) 290-295
18. Fingerut E., Gutter B., Meir R., Eliahoo D., and Pitcovski J. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine 23 (2005) 4685-4696
19. Tammi R., Jansen C.T., and Santti R. Histometric analysis of human skin in organ culture. J Invest Dermatol 73 2 (1979) 138-140
20. Romani N., Holzmann S., Tripp C.H., Koch F., and Stoitzner P. Langerhans cells-dendritic cells of the epidermis. APMIS 111 (2003) 725-740
21. Simmons C.P., Mastroeni P., Fowler R., Ghaem-maghami M., Lycke N., Pizza M., et al. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants. J Immunol 163 (1999) 6502-6510
22. Godefroy S., Goestch L., Plotnicky-Gilquin H., Nguyen T.N., Schmitt D., Staquet M.J., et al. Immunization onto shaved skin with a bacterial enterotoxin adjuvant protects mice against respiratory syncytial virus (RSV). Vaccine 2 (2003) 1665-1671
23. Kahlon R., Hu Y., Orteu C.H., Kifayet A., Trudeau J.D., Tan R., et al. Optimization of epicutaneous immunization for the induction of CTL. Vaccine 21 (2003) 2890-2899
24. El-Ghorr A.A., Williams R.M., Heap C., and Norval M. Transcutaneous immunisation with herpes simplex virus stimulates immunity in mice. FEMS Immunol Med Microbiol 29 (2000) 255-261
25. George-Chandy A., Eriksson K., Lebens M., Nordstrom I., Schon E., and Holmgren J. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69 (2001) 5716-5725
26. Haicheur N., Bismuth E., Bosset S., Adotevi O., Warnier G., Lacabanne V., et al. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J Immunol 165 (2000) 3301-3308
27. Allan R.S., Smith C.M., Belz G.T., van Lint A.L., Wakim L.M., Heath W.R., et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301 (2003) 1856-1857
28. Ritter U., Meissner A., Scheidig C., and Korner H. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 34 (2004) 1542-1550
29. Dickinson B.L., and Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63 (1995) 1617-1623
30. Williams N.A. Immune modulation by the cholera-like enterotoxin B-subunits. Int J Med Microbiol 290 (2000) 447-453